Imaging Apoptosis in Cancer with 99mTc-Hynic-rh-Annexin V
Author Information
Author(s): Kartachova M.S., Verheij M., van Eck B.L., Hoefnagel C.A., Olmos R.A. Valdes
Primary Institution: The Netherlands Cancer Institute/Antoni van Leeuwenhoek Hospital
Hypothesis
Can 99mTc-Hynic-rh-Annexin V scintigraphy predict therapy outcomes in cancer patients?
Conclusion
The study suggests that early increases in tumor tracer uptake can predict favorable therapy outcomes within 48 hours of treatment initiation.
Supporting Evidence
- Early therapy-induced changes in tracer uptake correlate well with therapy outcomes.
- Sequential imaging can predict therapy outcomes within 48 hours after treatment starts.
- Moderate baseline tracer accumulation was observed in patients with low grade lymphomas.
Takeaway
This study shows that a special imaging technique can help doctors see if cancer treatment is working just two days after it starts.
Methodology
The study involved using 99mTc-Hynic-rh-Annexin V scintigraphy to visualize apoptosis in tumors and correlate tracer uptake with therapy outcomes.
Limitations
Moderate tumor-to-background ratio and therapy-induced changes in normal tissues could confound image analysis.
Participant Demographics
Patients with low grade lymphomas and other malignancies.
Want to read the original?
Access the complete publication on the publisher's website